Evidence map›Paper›PMID 31133641›Full record

ArticleScientific reports2019

BD-2 and BD-3 increase skin flap survival in a model of ischemia and Pseudomonas aeruginosa infection.

Diogo Casal, Inês Iria, José S Ramalho, Sara Alves, Eduarda Mota-Silva, Luís Mascarenhas-Lemos, Carlos Pontinha, Maria Guadalupe-Cabral, José Ferreira-Silva, Mário Ferraz-Oliveira and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Effects of Heat-KilledMicroorganisms · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Diogo CasalAnatomy Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal. diogo_bogalhao@yahoo.co.uk.ORCID http://orcid.org/0000-0002-5537-9340
Inês IriaUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Lisbon, Caparica, Portugal.
José S RamalhoCEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.
Sara AlvesPathology Department, Centro Hospitalar de Lisboa Central - Hospital de São José, Lisbon, Portugal.
Eduarda Mota-SilvaLIBPhys, Physics Department, Faculdade de Ciências e Tecnologias, Universidade NOVA de Lisboa, Lisbon, Caparica, Portugal.
Luís Mascarenhas-LemosAnatomy Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.
Carlos PontinhaAnatomy Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-1265-949X
Maria Guadalupe-CabralCEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.
José Ferreira-SilvaPathology Department, Centro Hospitalar de Lisboa Central - Hospital de São José, Lisbon, Portugal.
Mário Ferraz-OliveiraPathology Department, Centro Hospitalar de Lisboa Central - Hospital de São José, Lisbon, Portugal.
Valentina VassilenkoLIBPhys, Physics Department, Faculdade de Ciências e Tecnologias, Universidade NOVA de Lisboa, Lisbon, Caparica, Portugal.ORCID http://orcid.org/0000-0002-7913-7047
João Goyri-O'NeillAnatomy Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.
Diogo PaisAnatomy Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.
Paula A VideiraUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Lisbon, Caparica, Portugal. p.videira@fct.unl.pt.ORCID http://orcid.org/0000-0001-5987-2485
Universidade Nova de Lisboa · PTHospital de São José · PTUnidade Local de Saúde de São José · PTUninova · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 10

Indexed as

AnimalsAnti-Bacterial Agentsbeta-DefensinsDisease Models, AnimalGenetic TherapyGenetic VectorsGraft SurvivalHumansIschemiaMalePseudomonas aeruginosaPseudomonas InfectionsRatsRats, WistarSkin TransplantationSurgical FlapsAnti-Bacterial Agentsbeta-DefensinsDEFB103A protein, humanDEFB4A protein, human

Identifiers

PMID31133641
PMCPMC6536547
OpenAlexW2946248256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.